Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Reboxetine
Drug ID BADD_D01919
Description Reboxetine is an antidepressant drug used in the treatment of clinical depression, panic disorder and ADD/ADHD. Its mesylate (i.e. methanesulfonate) salt is sold under tradenames including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra. Reboxetine has two chiral centers, but it only exists as two enantiomers, (R,R)-(-)- and (S,S)-(+)-reboxetine.
Indications and Usage For the treatment of clinical depression.
Marketing Status Not Available
ATC Code N06AX18
DrugBank ID DB00234
KEGG ID D08472
MeSH ID D000077593
PubChem ID 127151
TTD Drug ID D0N8FQ
NDC Product Code Not Available
Synonyms Reboxetine | Reboxetine Mesylate | 2-((2-Ethoxyphenoxy)benzyl)morpholine methanesulfonate | Vestra
Chemical Information
Molecular Formula C19H23NO3
CAS Registry Number 71620-89-8
SMILES CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Mydriasis17.02.11.003; 06.05.03.004--Not Available
Myocardial ischaemia02.02.02.008; 24.04.04.010--Not Available
Nausea07.01.07.001--
Neck pain15.03.04.009--
Nervous system disorder17.02.10.001--Not Available
Nervousness19.06.02.003--Not Available
Neurosis19.06.01.001--Not Available
Orthostatic hypotension24.06.03.004; 17.05.01.020--Not Available
Palpitations02.01.02.003--
Paraesthesia17.02.06.005--
Paranoia19.05.01.005--Not Available
Penis disorder21.12.01.001--Not Available
Peripheral coldness24.04.03.006; 08.01.09.010--Not Available
Peripheral vascular disorder24.03.01.003--Not Available
Personality disorder19.05.02.002--Not Available
Pharyngitis22.07.03.004; 11.01.13.003; 07.05.07.004--
Pollakiuria20.02.02.007--
Proctalgia07.03.02.001--
Prostatic disorder21.04.01.001--Not Available
Rash23.03.13.001--Not Available
Respiratory failure14.01.04.003; 22.02.06.002--
Rhinitis22.07.03.006; 11.01.13.004--
Salivary hypersecretion07.06.01.009--Not Available
Seborrhoeic dermatitis23.03.04.018--Not Available
Sexual dysfunction21.03.02.003; 19.08.05.002--Not Available
Shock24.06.02.002--Not Available
Sinus tachycardia02.03.03.010--
Sinusitis22.07.03.007; 11.01.13.005--
Skin disorder23.03.03.007--Not Available
Somnolence19.02.05.003; 17.02.04.006--
The 4th Page    First    Pre   4 5 6    Next   Last    Total 6 Pages